Lv5
1220 积分 2023-05-11 加入
Inhibition of CD40-CD154 costimulatory pathway by a cyclic peptide targeting CD154
8天前
已完结
Inhibition of CD40-CD154 costimulatory pathway by a cyclic peptide targeting CD154
10天前
已完结
Rationale for CD40 pathway blockade in autoimmune rheumatic disorders
10天前
已完结
Population Pharmacokinetic and Exposure-Response Analysis of Weekly Teriparatide in Osteoporosis Patients
16天前
已完结
Efficacy and safety of the CD40 ligand inhibitor dapirolizumab pegol in systemic lupus erythematosus (PHOENYCS GO): a randomised, double-blind, placebo-controlled, phase 3 trial
17天前
已完结
Recent Advances in Peptide Linkers of Antibody–Drug Conjugates
1个月前
已完结
Linker Design for the Antibody Drug Conjugates: A Comprehensive Review
1个月前
已完结
Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy
1个月前
已完结
The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women
1个月前
已完结
Lessons Learned From the Development of Oral Calcitonin: The First Tablet Formulation of a Protein in Phase III Clinical Trials
1个月前
已完结
皖公网安备34019202002308
